Epoprostenol (aerosolized)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Epoprostenol (aerosolized), covering 2025-07-31 to 2025-07-31. Get the full timeline:
Most recent: Clinical Trial Update: VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB [Phase 2]